Active-control equivalence trials and antihypertensive agents.

Area of Science:

• Clinical Trials Methodology
• Pharmacological Research

Background:

• Active-control equivalence trials are crucial for comparing different drug classes.
• Assessing the validity of these trials requires specific methodological criteria beyond those for superiority trials.

Purpose of the Study:

• To identify key methodological features impacting the validity of active-control equivalence trials.
• To evaluate recent antihypertensive drug trials using these identified criteria.

Main Methods:

• Applied standard randomized clinical trial criteria.
• Utilized six additional criteria specific to active-control equivalence trials.
• Assessed four large, recently published trials comparing different antihypertensive classes.

Main Results:

• All four trials met standard criteria for randomized trials.
• None of the trials met all six additional validity criteria for equivalence trials.
• One trial met five criteria, two met two criteria, and one met none.

Conclusions:

• Standard criteria for superiority trials are inadequate for interpreting active-control equivalence trials.
• The proposed methodological criteria enhance the assessment of active-control equivalence trial validity.
• These criteria are applicable beyond antihypertensive trials to various intervention studies.